RxDoctor Payments Data

Emily Clark, DO

Geriatric Psychiatry · Rochester, NYNPI 1588050587

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,385 of the $2,770 with a category attached, or 86.1%. Eisai Inc. accounts for 97.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $2,701 and has fallen 98.8% since, to $32 in 2024.

$2,770in general payments, 2019–2025

Across 19 payments — averaging $145.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$3K
  • Biogen$37
  • AstraZeneca$32
$655,689in research payments, 2019–2025

Across 10 payments — averaging $65,569 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$655K
  • E.r. Squibb & Sons, L.L.C.$1K

What the payments were for

  • Travel & lodging$2,38586%
  • Food & beverage$38514%

General payments by program year

21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.17$2,701
Biogen1$37
AstraZeneca1$32

How this compares

$2,770 in reported general payments places this provider in the 80th percentile of 45 geriatric psychiatry providers in New York.

See all geriatric psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$14,296
Medicare patients
75
Services billed
135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Memantine Hcl ErMemantine Hcl61$9,370
Rivastigmine47$5,507
Memantine Hcl175$5,190
Galantamine ErGalantamine Hbr49$4,617
Donepezil Hcl207$1,935
Escitalopram Oxalate141$1,779
Quetiapine Fumarate45$1,376
Duloxetine Hcl14$602
Olanzapine39$584
Mirtazapine51$566
Trazodone Hcl67$523
Bupropion XlBupropion Hcl30$387
Sertraline Hcl56$338
Venlafaxine Hcl ErVenlafaxine Hcl18$293
Risperidone23$268

Paid to pharmacies, not to this prescriber.

Other geriatric psychiatry in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →